Bridgewater headquartered Amneal Pharmaceuticals Inc, a global biopharmaceutical company, and mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, announced that ...
MADRID, Dec. 22, 2025 /PRNewswire/ -- mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, and Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") (NASDAQ: ...
Boncresa is supplied as a 60mg/mL single-dose prefilled syringe for SC injection and Oziltus is supplied as a 120mg/1.7mL single-dose vial for SC injection. Boncresa is approved to treat ...
The issuer is solely responsible for the content of this announcement. MADRID, Dec. 22, 2025 /PRNewswire/ -- mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, ...
Amneal Pharmaceuticals and mAbxience received Food and Drug Administration approval for two biosimilars. The companies said Monday that the FDA greenlit Biologics Licensing Applications for Boncresa, ...
Ellen and Tanya have both lost weight using GLP-1s but have had very different experiences when it comes to stopping the medication "It's like a switch that goes on and you're instantly starving." ...
Leqvio (inclisiran) is a prescription drug used to help treat certain types of high cholesterol. Leqvio comes in a prefilled syringe for injection under the skin. Leqvio contains the active drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback